rs397514535

Variant summary

Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP2PP5_Very_Strong

The NM_001378452.1(ITPR1):​c.4684G>A​(p.Val1562Met) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: not found (cov: 32)

Consequence

ITPR1
NM_001378452.1 missense

Scores

6
6
7

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:10

Conservation

PhyloP100: 6.69
Variant links:
Genes affected
ITPR1 (HGNC:6180): (inositol 1,4,5-trisphosphate receptor type 1) This gene encodes an intracellular receptor for inositol 1,4,5-trisphosphate. Upon stimulation by inositol 1,4,5-trisphosphate, this receptor mediates calcium release from the endoplasmic reticulum. Mutations in this gene cause spinocerebellar ataxia type 15, a disease associated with an heterogeneous group of cerebellar disorders. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 11 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in the ITPR1 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 44 curated pathogenic missense variants (we use a threshold of 10). The gene has 31 curated benign missense variants. Gene score misZ: 5.5951 (above the threshold of 3.09). Trascript score misZ: 6.2026 (above the threshold of 3.09). GenCC associations: The gene is linked to spinocerebellar ataxia type 15/16, aniridia-cerebellar ataxia-intellectual disability syndrome, spinocerebellar ataxia type 29.
PP5
Variant 3-4706193-G-A is Pathogenic according to our data. Variant chr3-4706193-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 39571.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-4706193-G-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ITPR1NM_001378452.1 linkc.4684G>A p.Val1562Met missense_variant Exon 37 of 62 ENST00000649015.2 NP_001365381.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ITPR1ENST00000649015.2 linkc.4684G>A p.Val1562Met missense_variant Exon 37 of 62 NM_001378452.1 ENSP00000497605.1 Q14643-1
ITPR1ENST00000354582.12 linkc.4657G>A p.Val1553Met missense_variant Exon 37 of 62 5 ENSP00000346595.8 A0A3F2YNW8
ITPR1ENST00000648266.1 linkc.4657G>A p.Val1553Met missense_variant Exon 37 of 62 ENSP00000498014.1 A0A3B3IU04
ITPR1ENST00000650294.1 linkc.4639G>A p.Val1547Met missense_variant Exon 36 of 61 ENSP00000498056.1 A0A3B3ITU8
ITPR1ENST00000443694.5 linkc.4639G>A p.Val1547Met missense_variant Exon 36 of 61 1 ENSP00000401671.2 Q14643-2
ITPR1ENST00000648309.1 linkc.4612G>A p.Val1538Met missense_variant Exon 34 of 59 ENSP00000497026.1 Q14643-5
ITPR1ENST00000357086.10 linkc.4657G>A p.Val1553Met missense_variant Exon 37 of 59 1 ENSP00000349597.4 Q14643-3
ITPR1ENST00000456211.8 linkc.4612G>A p.Val1538Met missense_variant Exon 36 of 58 1 ENSP00000397885.2 Q14643-4
ITPR1ENST00000648038.1 linkc.2494G>A p.Val832Met missense_variant Exon 18 of 42 ENSP00000497872.1 A0A3B3ITQ1
ITPR1ENST00000648431.1 linkc.1984G>A p.Val662Met missense_variant Exon 15 of 39 ENSP00000498149.1 A0A3B3IU05
ITPR1ENST00000648212.1 linkc.1591G>A p.Val531Met missense_variant Exon 13 of 39 ENSP00000498022.1 A0A3B3IU13

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00152
Hom.:
0

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:5
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Oct 23, 2020
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Aug 26, 2024
GeneDx
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Published functional studies demonstrate a damaging effect: abolished interaction with carbonic anhydrase-related protein VIII (CA8) and CA8-mediated inhibition of ITPR1 (PMID: 30429331); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 11445634, 28659154, 23495097, 14981189, 31730387, 32290556, 26770814, 25794864, 28620721, 27062503, 37964426, 38860480, 30429331, 22986007) -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Aug 01, 2019
CeGaT Center for Human Genetics Tuebingen
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Spinocerebellar ataxia type 29 Pathogenic:2
Dec 28, 2004
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Sep 20, 2024
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Loss of function and gain of function are known mechanisms of disease in this gene and are associated with spinocerebellar ataxia 29, congenital nonprogressive (MIM#117360), Gillespie syndrome (MIM#206700), and spinocerebellar ataxia 15 (MIM#606658). Missense variants have been reported to cause both loss and gain of function mechanisms (PMIDs: 28620721, 29925855, OMIM), while variants resulting in a truncated protein have been reported to cause loss of function only (PMID: 29925855). (I) 0108 - This gene is associated with both recessive and dominant disease. Only biallelic truncating variants have been reported for recessive Gillespie syndrome (MIM#206700) (PMID: 29925855), but otherwise there is no clear genotype-phenotype correlation regarding the location of a variant and its associated condition. (I) 0200 - Variant is predicted to result in a missense amino acid change from valine to methionine. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been classified as pathogenic by multiple clinical laboratories in ClinVar, and observed in individuals with ITPR1-related features (DECIPHER, PMID: 26770814). (SP) 0901 - This variant has strong evidence for segregation with disease. This variant has been reported to segregate with spinocerebellar ataxia in many affected individuals from this individual's family, and another unrelated family (PMIDs: 26770814, 22986007). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -

Inborn genetic diseases Pathogenic:1
Jan 12, 2017
Ambry Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Neurodevelopmental disorder Pathogenic:1
May 12, 2023
Laboratory of Molecular Genetics (Pr. Bezieau's lab), CHU de Nantes
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Spinocerebellar ataxia type 15/16 Pathogenic:1
Jun 01, 2022
Solve-RD Consortium
Significance: Likely pathogenic
Review Status: no assertion criteria provided
Collection Method: provider interpretation

Variant confirmed as disease-causing by referring clinical team -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.69
BayesDel_addAF
Pathogenic
0.29
D
BayesDel_noAF
Pathogenic
0.18
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.51
.;.;.;.;.;.;D;.;.;.;.
Eigen
Uncertain
0.61
Eigen_PC
Pathogenic
0.67
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.93
D;D;D;D;D;D;D;D;.;D;D
M_CAP
Benign
0.038
D
MetaRNN
Uncertain
0.60
D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
-0.36
T
MutationAssessor
Benign
1.6
.;.;.;.;.;.;L;.;.;.;.
PrimateAI
Pathogenic
0.89
D
PROVEAN
Benign
-1.2
N;N;.;N;.;.;.;.;N;.;.
REVEL
Uncertain
0.38
Sift
Benign
0.31
T;T;.;T;.;.;.;.;T;.;.
Sift4G
Benign
0.39
T;T;.;T;.;.;.;.;T;.;.
Polyphen
1.0
.;.;.;.;.;.;D;.;.;.;.
Vest4
0.54
MutPred
0.33
.;.;.;.;.;.;Gain of helix (P = 0.062);.;.;.;.;
MVP
0.65
MPC
1.8
ClinPred
0.96
D
GERP RS
5.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.27
gMVP
0.50

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs397514535; hg19: chr3-4747877; API